Search Within

Michael Morris

  1. "Nagavarakishore Pillarsetty"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Radiochemistry and Imaging Sciences Service (6)
  4. Radiology, Department of (6)
  5. Sloan Kettering Institute Postdocs (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Nagavarakishore Pillarsetty (6)
  2. Goutam Chakraborty (4)
  3. Philip Kantoff (4)
  4. Rahim Hirani (4)
  5. Sai Harisha Rajanala (4)
  6. Subhiksha Nandakumar (4)

More People

Years
  1. 2025 (1)
  2. 2022 (3)
  3. 2021 (2)
Publications
  1. Cancer Research (1)
  2. Cell Reports (1)
  3. Clinical Cancer Research (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Nuclear Medicine (1)
  6. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. National Academy of Sciences (1)
  5. Society of Nuclear Medicine (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
    Journal Article

    Hirani, R.; Nandakumar, S.; Zaman, N.; Prabhakaraalva, P.; King, S. A.; Kalidindi, T. M.; Ghale, R.; Rajanala, S. H.; Fidele, D. C.; De Stanchina, E.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Molecular imaging of neuroendocrine prostate cancer by targeting delta-like ligand 3
    Journal Article

    Korsen, J. A.; Kalidindi, T. M.; Khitrov, S.; Samuels, Z. V.; Chakraborty, G.; Gutierrez, J. A.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
    Journal Article

    Korsen, J. A.; Gutierrez, J. A.; Tully, K. M.; Carter, L. M.; Samuels, Z. V.; Khitrov, S.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save